Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease

Numerous studies have described specific metabolites as biomarkers of severe liver diseases, but very few have measured gut microbiota (GM)-produced metabolites in fatty liver disease. We aimed at finding GM signatures and metabolite markers in plasma and feces related to high liver fat content. Bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Driuchina, Anastasiia, Hintikka, Jukka, Lehtonen, Marko, Keski-Rahkonen, Pekka, O’Connell, Thomas, Juvonen, Risto, Kuula, Juho, Hakkarainen, Antti, Laukkanen, Jari A., Mäkinen, Elina, Lensu, Sanna, Pietiläinen, Kirsi H., Pekkala, Satu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973343/
https://www.ncbi.nlm.nih.gov/pubmed/36715540
http://dx.doi.org/10.1128/mbio.02663-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973343/
https://www.ncbi.nlm.nih.gov/pubmed/36715540
http://dx.doi.org/10.1128/mbio.02663-22

Ejemplares similares